SEC INSIDER TRANSACTIONS

VERTEX PHARMACEUTICALS INC / MA (VRTX) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

VRTX · VERTEX PHARMACEUTICALS INC / MA

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Stale snapshot · Covered: filings 2026-10-15 to 2026-10-27 · 4 filings · fetched 2026-10-27T16:22:24Z

View six-calendar-month insider history →

Recent reported activity

0purchase rows on this page

0sale rows on this page

3matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-10-20Filed 2026-10-22	Brennan Daniel J.Director Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. References: F1	A Award / grantCommon Stock · Non-derivative	795A	503.47	Direct	Form 4 ↗0000875320-26-000283
2026-10-15Filed 2026-10-19	Garber Alan MDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death. References: F1	A Award / grantDeferred Stock Units · Derivative	29.272A	512.44	Direct	Form 4 ↗0000875320-26-000274
2026-10-15Filed 2026-10-19	SACHS BRUCE IDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. References: F1	A Award / grantDeferred Stock Units · Derivative	92.694A	512.44	Direct	Form 4 ↗0000875320-26-000276

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.